|
Aug 8
|
Masimo (MASI) Q2 Earnings Miss Estimates
|
|
Aug 8
|
Masimo Reports Second Quarter 2023 Financial Results
|
|
Aug 7
|
Investors in Masimo (NASDAQ:MASI) have unfortunately lost 43% over the last three years
|
|
Feb 3
|
Hedge fund lobby group supports shareholder rights in Masimo case
|
|
Jan 30
|
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
|